
Company valuation, historical trends, and peer comparisons.
According to United Therapeutics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 23.74B. This represents a change of 14.02% compared to the average of 20.82B of the last 4 quarters.
The mean historical Enterprise Value of United Therapeutics Corporation over the last ten years is 9.29B. The current 23.74B Enterprise Value has changed 155.65% with respect to the historical average. Over the past ten years (40 quarters), UTHR's Enterprise Value was at its highest in in the March 2026 quarter at 24.72B. The Enterprise Value was at its lowest in in the June 2019 quarter at 3.76B.
Average
9.29B
Median
8.19B
Minimum
3.97B
Maximum
20.07B
Discovering the peaks and valleys of United Therapeutics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.56%
Maximum Annual Enterprise Value = 20.07B
Minimum Annual Increase = -28.68%
Minimum Annual Enterprise Value = 3.97B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 20.07B | 37.90% |
| 2024 | 14.55B | 48.74% |
| 2023 | 9.78B | -21.68% |
| 2022 | 12.49B | 30.03% |
| 2021 | 9.61B | 41.90% |
| 2020 | 6.77B | 70.56% |
| 2019 | 3.97B | -8.07% |
| 2018 | 4.32B | -28.68% |
| 2017 | 6.05B | 15.13% |
| 2016 | 5.26B | -17.54% |
The current Enterprise Value of United Therapeutics Corporation (UTHR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
14.80B
5-year avg
13.30B
10-year avg
9.29B
United Therapeutics Corporation’s Enterprise Value is greater than Inhibikase Therapeutics, Inc. (179.49M), greater than Liquidia Corporation (3.69B), less than Insmed Incorporated (24.68B), greater than Travere Therapeutics, Inc. (5.14B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 179.49M | $210.70M | |
| 3.69B | $3.84B | |
| 24.68B | $24.34B | |
| 5.14B | $4.65B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like United Therapeutics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like United Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is United Therapeutics Corporation's Enterprise Value?
What is the highest Enterprise Value for United Therapeutics Corporation (UTHR)?
What is the 3-year average Enterprise Value for United Therapeutics Corporation (UTHR)?
What is the 5-year average Enterprise Value for United Therapeutics Corporation (UTHR)?
How does the current Enterprise Value for United Therapeutics Corporation (UTHR) compare to its historical average?